Page last updated: 2024-08-25

rosiglitazone and o-desmethylindomethacin

rosiglitazone has been researched along with o-desmethylindomethacin in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bansal, G; Garg, V; Maurya, RK; Monga, V; Thanikachalam, PV1
Feng, CR; He, QJ; Li, Y; Li, YY; Tang, L; Wu, HS; Yang, B; Yang, YS; Yu, JH1

Reviews

1 review(s) available for rosiglitazone and o-desmethylindomethacin

ArticleYear
An insight into the medicinal perspective of synthetic analogs of indole: A review.
    European journal of medicinal chemistry, 2019, 10-15, Volume: 180

    Topics: Animals; Anti-HIV Agents; Anti-Infective Agents; Antihypertensive Agents; Antimalarials; Antitubercular Agents; Humans; Hypoglycemic Agents; Indoles; Molecular Structure; Structure-Activity Relationship

2019

Other Studies

1 other study(ies) available for rosiglitazone and o-desmethylindomethacin

ArticleYear
The potential insulin sensitizing and glucose lowering effects of a novel indole derivative in vitro and in vivo.
    Pharmacological research, 2007, Volume: 56, Issue:4

    Topics: 3T3-L1 Cells; Adipocytes; Adiponectin; Animals; Blood Glucose; Cell Differentiation; Cell Line, Tumor; Glucose; Glucose Transporter Type 4; Humans; Hypoglycemic Agents; In Vitro Techniques; Indoleacetic Acids; Indoles; Insulin; Insulin Resistance; Leptin; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; PPAR alpha; PPAR gamma; Resistin; RNA, Messenger; Rosiglitazone; Signal Transduction; Thiazolidinediones

2007